News & Articles

APOE genotyping allows assessment of a patient’s risk for adverse effects from new anti-amyloid therapy for Alzheimer’s

Successes across the de-extinction pipeline signal that the thylacine project is on track as Colossal continues its global effort to fight the extinction crisis

Upgraded MassFluidix HC system launched in response to customer feedback, optimizing efficiency and quality of mass photometry experiments

BioPORTER protein delivery reagent from AMSBIO is proven to efficiently transport functionally active proteins directly into living cells eliminating the traditional DNA transfection, transcription, and protein translation process.

Register now to join our 3-part webinar series from October

The partnership will incorporate CrestOptics' CICERO spinning disk imaging unit within Leica Microsystems' THUNDER Imager Cell system

The Vericheck ddPCR Empty-Full Capsid Kit from Bio-Rad combines measuring viral titer and capsid titer, providing a high-precision assessment of both protein and DNA in droplets

This guest editorial from Techcomp Lab Products explores methane gas, its worldwide implications, and how we can reduce its greenhouse gas affects

Collaborative project to develop next-generation cell platform for viral vector production receives £1.1 million grant from Innovate UK & NRC

In this guest editorial from INTEGRA Biosciences discover how NGS has transformed genomic research since its initial development, broadening our understanding of genetic variation and gene expression

Gri3D® is an all-in-one microwell plate allowing researchers in drug development and academia to establish and automate front-to-end 3D cell culture workflows.

Discover the benefits of incorporating spectral technology in the lab to advance your flow cytometry research

Through this partnership, Axion and STEMCELL will enable scientists to examine the complex interactions between electrical cells in vitro, driving mechanistic disease research and propelling therapeutic development in neural and cardiac fields

OCREVUS ZUNOVO has the potential to expand treatment options to centers without IV infrastructure or with IV constraints

The first enzymatic solution for complete removal of chromatin at physiological salt conditions and its effect on down stream processing